Click for best price
Chemotherapy Induced Nausea Vomiting CINV Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 2125.8 million
|
Forecast Market size by 2029 |
US$ 2819.2 million
|
| Growth Rate |
CAGR of 4.1% |
Number of Pages |
79 Pages |
Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.
This report aims to provide a comprehensive presentation of the global market for Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemotherapy Induced Nausea and Vomiting (CINV) Drugs. This report contains market size and forecasts of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs in global, including the following market information:
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Chemotherapy Induced Nausea and Vomiting (CINV) Drugs companies in 2022 (%)
The global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market was valued at US$ 2125.8 million in 2022 and is projected to reach US$ 2819.2 million by 2029, at a CAGR of 4.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs key players include Merck, Eisai, Mundipharma, etc. Global top three manufacturers hold a share over 50%.
North America is the largest market, with a share about 50%, followed by China, and Europe both have a share about 35 percent.
In terms of product, 5-HT3 Inhibitors is the largest segment, with a share over 60%. And in terms of application, the largest application is Moderately Emetogenic Chemotherapy, followed by Highly Emetogenic Chemotherapy, Low Emetogenic Chemotherapy, etc.
We surveyed the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Segment Percentages, by Type, 2022 (%)
5-HT3 Inhibitors
NK1 Inhibitors
Other
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Segment Percentages, by Application, 2022 (%)
Highly Emetogenic Chemotherapy
Moderately Emetogenic Chemotherapy
Low Emetogenic Chemotherapy
Other
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chemotherapy Induced Nausea and Vomiting (CINV) Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Chemotherapy Induced Nausea and Vomiting (CINV) Drugs revenues share in global market, 2022 (%)
Key companies Chemotherapy Induced Nausea and Vomiting (CINV) Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Chemotherapy Induced Nausea and Vomiting (CINV) Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Heron Therapeutics
Roche
Mylan
Tesaro
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, market overview.
Chapter 2: Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 2125.8 million
|
| Forecast Market size by 2029 |
US$ 2819.2 million
|
| Growth Rate |
CAGR of 4.1% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
79 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Overall Market Size
2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size: 2022 VS 2029
2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Players in Global Market
3.2 Top Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Companies Ranked by Revenue
3.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Companies
3.4 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Companies
3.5 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Players in Global Market
3.8.1 List of Global Tier 1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Markets, 2022 & 2029
4.1.2 5-HT3 Inhibitors
4.1.3 NK1 Inhibitors
4.1.4 Other
4.2 By Type - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue & Forecasts
4.2.1 By Type - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, 2018-2023
4.2.2 By Type - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, 2024-2029
4.2.3 By Type - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales & Forecasts
4.3.1 By Type - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, 2018-2023
4.3.2 By Type - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, 2024-2029
4.3.3 By Type - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2022 & 2029
5.1.2 Highly Emetogenic Chemotherapy
5.1.3 Moderately Emetogenic Chemotherapy
5.1.4 Low Emetogenic Chemotherapy
5.1.5 Other
5.2 By Application - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue & Forecasts
5.2.1 By Application - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, 2018-2023
5.2.2 By Application - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, 2024-2029
5.2.3 By Application - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales & Forecasts
5.3.1 By Application - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, 2018-2023
5.3.2 By Application - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, 2024-2029
5.3.3 By Application - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2022 & 2029
6.2 By Region - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue & Forecasts
6.2.1 By Region - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, 2018-2023
6.2.2 By Region - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, 2024-2029
6.2.3 By Region - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales & Forecasts
6.3.1 By Region - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, 2018-2023
6.3.2 By Region - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, 2024-2029
6.3.3 By Region - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, 2018-2029
6.4.2 By Country - North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, 2018-2029
6.4.3 US Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2018-2029
6.4.4 Canada Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2018-2029
6.4.5 Mexico Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, 2018-2029
6.5.3 Germany Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2018-2029
6.5.4 France Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2018-2029
6.5.5 U.K. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2018-2029
6.5.6 Italy Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2018-2029
6.5.7 Russia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2018-2029
6.5.9 Benelux Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, 2018-2029
6.6.3 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2018-2029
6.6.4 Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2018-2029
6.6.5 South Korea Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2018-2029
6.6.7 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, 2018-2029
6.7.2 By Country - South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, 2018-2029
6.7.3 Brazil Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2018-2029
6.7.4 Argentina Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, 2018-2029
6.8.3 Turkey Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2018-2029
6.8.4 Israel Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2018-2029
6.8.6 UAE Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Major Product Offerings
7.1.4 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Eisai
7.2.1 Eisai Company Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Major Product Offerings
7.2.4 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Eisai Key News & Latest Developments
7.3 Mundipharma
7.3.1 Mundipharma Company Summary
7.3.2 Mundipharma Business Overview
7.3.3 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Major Product Offerings
7.3.4 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Mundipharma Key News & Latest Developments
7.4 Qilu Pharma
7.4.1 Qilu Pharma Company Summary
7.4.2 Qilu Pharma Business Overview
7.4.3 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Major Product Offerings
7.4.4 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Qilu Pharma Key News & Latest Developments
7.5 Teva
7.5.1 Teva Company Summary
7.5.2 Teva Business Overview
7.5.3 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Major Product Offerings
7.5.4 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Teva Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Major Product Offerings
7.6.4 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 Heron Therapeutics
7.7.1 Heron Therapeutics Company Summary
7.7.2 Heron Therapeutics Business Overview
7.7.3 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Major Product Offerings
7.7.4 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Heron Therapeutics Key News & Latest Developments
7.8 Roche
7.8.1 Roche Company Summary
7.8.2 Roche Business Overview
7.8.3 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Major Product Offerings
7.8.4 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Roche Key News & Latest Developments
7.9 Mylan
7.9.1 Mylan Company Summary
7.9.2 Mylan Business Overview
7.9.3 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Major Product Offerings
7.9.4 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Mylan Key News & Latest Developments
7.10 Tesaro
7.10.1 Tesaro Company Summary
7.10.2 Tesaro Business Overview
7.10.3 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Major Product Offerings
7.10.4 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Tesaro Key News & Latest Developments
8 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production Capacity, Analysis
8.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production Capacity, 2018-2029
8.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Supply Chain Analysis
10.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Value Chain
10.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Upstream Market
10.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs in Global Market
Table 2. Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Type
Table 9. List of Global Tier 1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, (K Units), 2024-2029
Table 46. Merck Company Summary
Table 47. Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offerings
Table 48. Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. Eisai Company Summary
Table 51. Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offerings
Table 52. Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Eisai Key News & Latest Developments
Table 54. Mundipharma Company Summary
Table 55. Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offerings
Table 56. Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Mundipharma Key News & Latest Developments
Table 58. Qilu Pharma Company Summary
Table 59. Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offerings
Table 60. Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Qilu Pharma Key News & Latest Developments
Table 62. Teva Company Summary
Table 63. Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offerings
Table 64. Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Teva Key News & Latest Developments
Table 66. Novartis Company Summary
Table 67. Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offerings
Table 68. Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Novartis Key News & Latest Developments
Table 70. Heron Therapeutics Company Summary
Table 71. Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offerings
Table 72. Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Heron Therapeutics Key News & Latest Developments
Table 74. Roche Company Summary
Table 75. Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offerings
Table 76. Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Roche Key News & Latest Developments
Table 78. Mylan Company Summary
Table 79. Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offerings
Table 80. Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Mylan Key News & Latest Developments
Table 82. Tesaro Company Summary
Table 83. Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offerings
Table 84. Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Tesaro Key News & Latest Developments
Table 86. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production by Region, 2018-2023 (K Units)
Table 89. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production by Region, 2024-2029 (K Units)
Table 90. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Opportunities & Trends in Global Market
Table 91. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Drivers in Global Market
Table 92. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Restraints in Global Market
Table 93. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Raw Materials
Table 94. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Downstream
Table 96. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Downstream Clients in Global Market
Table 97. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Type in 2022
Figure 2. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Application in 2022
Figure 3. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue in 2022
Figure 9. By Type - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share, 2018-2029
Figure 23. US Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share, 2018-2029
Figure 28. Germany Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share, 2018-2029
Figure 37. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Region, 2022 VS 2029
Figure 54. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Value Chain
Figure 55. Marketing Channels
